Manhattan Scientifics
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
244 5th Ave Ste 2341, New York City, New...Phone Number
(212) 541-2405Website
www.mhtx.comRevenue
<$5 MillionStock Symbol
MHTXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Manhattan Scientifics
Manhattan Scientifics operates at the intersection of advanced materials science and medical innovation, specializing in the commercialization of transformative technologies within the nanomedicine sector. The company focuses on translating cutting-edge scientific research into practical medical applications that address significant clinical needs. The organization has developed specialized expertise in ultra-fine grain metals, leveraging these advanced materials to create next-generation medical prosthetics. This technical foundation enables the company to produce devices with enhanced biocompatibility and performance characteristics. By combining materials science with biomedical engineering, Manhattan Scientifics works to advance prosthetic solutions that improve patient outcomes and quality of life. Beyond prosthetics, the company actively pursues commercialization of cancer research and nanomedicine applications developed through its scientific divisions. This dual focus reflectsRead more
Manhattan Scientifics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Manhattan Scientifics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Manhattan Scientifics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Manhattan Scientifics has new funding data
Check out if Manhattan Scientifics is spiking on competitors!
Product Launch: Get notified when Manhattan Scientifics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Manhattan Scientifics
Earning: See what the market has to say on Manhattan Scientifics recently announced quarterly report
Check if Manhattan Scientifics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Manhattan Scientifics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Manhattan Scientifics
Find 3 more new buyers
Compare Similar Companies to Manhattan Scientifics
Compare insights from companies similar to Manhattan Scientifics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Manhattan Scientifics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Manhattan Scientifics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Manhattan Scientifics.
Manhattan Scientifics Tech Stack
A closer look at the technologies used by Manhattan Scientifics
Manhattan Scientifics News & Media
Manhattan Scientifics Celebrates Imagion Biosystems' Milestones in Early Cancer Detection Technology
NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTCQB: MHTX), which provided the initial funding &, currently owns more than 50 million shares of Imagion Biosystems Ltd. celebrates Imagion's remarkable progress in early cancer detection technology. In 2022, Imagion unveiled groundbreaking imaging agent technology, displaying promising safety in real breast cancer patients during Phase 1 studies. The company also pioneered a clinical study utilizing magnetic nanoparticles for targetedManhattan Scientifics Announces Early Results from Cancer Company
NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study. Imagion Biosystems Ltd. (IBX.AX) shares were up 46% trading 71 million shares. Manhattan Scientifics Inc., initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. About Manhattan Scientifics, Inc. Manhattan Scientifics Inc. (www.mhtx.com) is focused on technology transfer and commercialization ofManhattan Scientifics Cancer Imaging Asset Announces Progress on Australian Clinical Study
NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTC: QB), initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. (IBX.AX). Here we provide the reader with a televised interview with Imagion's CEO Bob Proulx. Stock Down Under Interview with Bob Proulx About Manhattan Scientifics, Inc. Manhattan Scientifics Inc. (www.mhtx.com) is focused on technology transfer and commercialization of transformative technologies. It has assisted incubating and fManhattan Scientifics Inc. Stock Chart Mimics That of Its Largest Investment to Date: Imagion Biosystems
NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTCQB: MHTX) invested $30 million and a 10-year effort to commercialize the Imagion Biosystems (IBX: AX) super early, non- invasive, non-radioactive Cancer diagnostic, now “partnered” with MD Anderson Cancer Center, Houston. The company is awaiting regulatory approval to initiate human cancer trials. View the stock chart. “Very early detection of cancer may ultimately lead to the end of the dreaded disease,” stated a senior cancer physician
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Manhattan Scientifics
Sign Up For FreeTo access detailed company insights
Manhattan Scientifics operates at the intersection of advanced materials science and medical innovation, specializing in the commercialization of transformative technologies within the nanomedicine sector. The company focuses on translating cutting-edge scientific research into practical medical applications that address significant clinical needs.... Read More
